Lead Frontend Software Developer - TMRW


: $82,360.00 - $140,080.00 /year *

Employment Type

: Full-Time


: Information Technology

Loading some great jobs for you...

THE RESPONSIBILITIES The Lead Frontend Software Developer will be responsible for architecting / development / deployment of our healthcare applications / products and managing off-shore team.The Lead Frontend Software Developer should have extensive experience in Vue.js and other frontend development toolsKEY DUTIES AND RESPONSIBILITIESManage and coach a team of talented off-shore front-end software engineersOwn and refine architecture of systems that span multiple teams and/or productsMaintain a culture that focuses on quality, continuous improvement and learning opportunitiesBuild UI front-end with vanilla Javascript and Vue.js for healthcare data productsDefine/design features for the product in an agile environmentHands on developmentDeliver user-facing visualizationsCoordinate with DevOps and Data Architecture teams to define data schematics and workflowTranslate user requirements into interactively designed interfaces for applications/productsSupport UX DesignREQUIREMENTSBachelor's in Computer Science or related with 5+ years of experienceProven initiative and ability to champion a project from conception through to implementationStrong desire to grow developers and improve existing practices to produce high-quality softwareExperience working in a test-driven development, or strong desire to implement and improve testing practicesExpertise in JavaScriptExtensive experience in Vue.jsExperience with one or more of the following: Angular, React, Backbone, EmberKnowledge of other tools you might need (git, Java, SQL, etc.)Mobile UX familiarityABOUT THE COMPANY Manhattan-based TMRW is a mission-driven company on track to become the first mover in automating the IVF lab by creating the first fertility cryostorage center of excellence in the world. TMRW features fully robotic freezers, 100 percent physical and digital chain of custody, continuous monitoring of egg and embryo samples and electronically integrated processes all overseen at the TMRW control center. The firm is structured in anticipation of an IPO with leading assisted reproductive technology (ART) physicians as customers, clinical partners and significant equity holders.ABOUT ASSISTED REPRODUCTIVE TECHNOLOGY (ART) It's becoming increasingly apparent that fertility medicine represents one of the triumphs of the last 50-years of medical history. Today, one in 20 children born in Japan is the result of ART. In Norway, the number is one in 10. Powerful, irreversible scientific and demographic forces are driving this development. Today the advantages of involving a fertility doctor in the process of conceiving a child are numerous and growing rapidly. For women, it allows them to better safeguard their fertility over a longer period of time. For all would-be parents, a growing list of devastating, often fatal genetic conditions (Tay Sachs, Sickle Cell Anemia, Cystic Fibrosis) can be screened against and easily avoided, affording the opportunity to end certain disease states within a generation. All of these advances are linked to the newly perfected technology of vitrification, the fast freezing of human embryos and oocytes (eggs). As the advantages of vitrification mount, ART is quickly becoming a freeze all clinical practice requiring both long-term and short term cryostorage in the next decade for millions of patients, up from only 5,000 just a few years ago. The existing cryostorage infrastructure in medical clinics can no longer accommodate this growing demand.ABOUT THE FOUNDERS TMRW s three co-founders Joshua Abram, Alan Murray and Jeff Port--- are serial entrepreneurs who have founded and led firms involved in diverse fields including data and analytics, biomedicine and hospitality. Prior to founding TMRW, Joshua and Alan operating through Coriolis Ventures founded and served as Co-CEOs of several venture-backed companies at the intersection of data, machine learning and marketing. These companies today employ approximately 1,000 people, mostly in Manhattan, and routinely process tens of billions of data events every 24 hours. While building these technology companies, Joshua and Alan also made significant commitment to founding and/or providing the earliest seed funding to firms that spoke to their shared interest in hospitality and innovative, commercial and saleable luxury experiences. They co-founded the paradigm-shifting NeueHouse, which brought the amenities and sensibility of a boutique hotel to the office environment and was widely celebrated for, as Departure Magazine wrote, fundamentally changing what one might aspire to in a utopian, perfected office. Joshua and Alan also provided the earliest seed funding to Alice, a hospitality technology company automating the guest experience at leading hotels which later received $30 million in funding from Expedia. Jeff Port is thoracic surgeon who, while practicing and teaching full-time at Weill Cornell Medical Center, founded RF Surgical which developed a now widely used technology to track items used by surgeons during complex operation to assure that nothing was left behind after wound closure. Companies founded by the TMRW principals have enjoyed exits totaling over $1 billion. - provided by Dice
Associated topics: asp, emberjs, frontend, html5, joomla, js, jscript, web designer, website, wordpress * The salary listed in the header is an estimate based on salary data for similar jobs in the same area. Salary or compensation data found in the job description is accurate.

Launch your career - Upload your resume now!

Upload your resume

Loading some great jobs for you...